Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesMonitoring Cholesterol Levels: Measurement Error or True Change
Annals of Internal Medicine, 05/09/08
Glasziou P et al. - This analysis of data from a trial that compared pravastatin with placebo in patients with coronary disease found that the signal–noise ratio in cholesterol monitoring was weak. Consider testing adherent patients with well-controlled cholesterol levels every 3 to 5 years rather than every few months or annually.
Related Articles
Pravastatin and cardiovascular risk in moderate chronic kidney disease
Atherosclerosis, 10/07/09
Relevance Score: 88%
Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan
Pharmacoepidemiology and Drug Safety, 10/27/09
Relevance Score: 87%
11C-meta-hydroxyephedrine defects persist despite functional improvement in hibernating myocardium
Journal of Nuclear Cardiology, 11/18/09
Relevance Score: 80%
Review: statins do not protect against development of dementia
Evidence-Based Mental Health, 10/30/09
Relevance Score: 80%
Today in Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Amlodipine/Valsartan/Hydrochlorothiazide: Fixed-Dose Combination in Hypertension
American Journal of Cardiovascular Drugs, 12/03/09
Primary and Secondary Prevention of Cardiovascular Disease in Older Adults: A Status Report
Clinics in Geriatric Medicine, 12/03/09
Cardiopulmonary Resuscitation for Bradycardia With Poor Perfusion Versus Pulseless Cardiac Arrest
Pediatrics, 12/03/09
Sponsor
Article Search
Sponsor